Remove invest
article thumbnail

UK Chancellor trumpets £650m AstraZeneca investment

pharmaphorum

A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s life sciences sector.

Packaging 109
article thumbnail

AbbVie invests €150m in new R&D facility in Germany

Pharmafile

AbbVie has announced that it is investing approximately €150m in its second largest research and development (R&D) facility worldwide. The post AbbVie invests €150m in new R&D facility in Germany appeared first on Pharmafile. The new facility is being built at Ludwigshafen, Germany.

64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Walgreens takes $6B hit in Q2 from VillageMD investment

Fierce Healthcare

Walgreens lost nearly $6 billion in its fiscal 2024 second quarter to write down the value of its investment in primary care clinic chain VillageMD. This is a developing story and will be updated following Walgreens' Q2 earnings call this morning.

122
122
article thumbnail

STAT+: Private equity investment in Medicare Advantage drops

STAT

Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report. But investors have found pockets of profits by backing companies involved in enrolling seniors in MA plans and keeping track of them once they’re there.

Insurance 120
article thumbnail

STAT+: Goldman Sachs launches $650 million fund for life science investments

STAT

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

144
144
article thumbnail

Fujifilm plans $1.2 billion investment in major US manufacturing facility

European Pharmaceutical Review

FUJIFILM Corporation is planning to invest $1.2 This news follows the organisation’s announcement of a $2 billion investment in the facility in March 2021. This additional financial boost totals the investment to over $3.2 This additional financial boost totals the investment to over $3.2 billion, FUJIFILM confirmed.

84
article thumbnail

Abenza announces investment in bioconjugation and ADC capabilities

Pharmafile

Abenza has announced a major investment in bioconjugation and antibody drug conjugate (ADC) capabilities in response to an increasing industry demand. The company intends to expand its bioconjugate development and cGMP manufacturing site in Bristol, Pennsylvania, US, with a $5m investment.

64